Functional characterization of the Mycobacterium abscessus genome coupled with condition specific transcriptomics reveals conserved molecular strategies for host adaptation and persistence

BackgroundMycobacterium abscessus subsp. abscessus (MAB) is a highly drug resistant mycobacterium and the most common respiratory pathogen among the rapidly growing non-tuberculous mycobacteria. MAB is also one of the most deadly of the emerging cystic fibrosis (CF) pathogens requiring prolonged treatment with multiple antibiotics. In addition to its “mycobacterial” virulence genes, the genome of MAB harbours a large accessory genome, presumably acquired via lateral gene transfer including homologs shared with the CF pathogens Pseudomonas aeruginosa and Burkholderia cepacia. While multiple genome sequences are available there is little functional genomics data available for this important pathogen.ResultsWe report here the first multi-omics approach to characterize the primary transcriptome, coding potential and potential regulatory regions of the MAB genome utilizing differential RNA sequencing (dRNA-seq), RNA-seq, Ribosome profiling and LC-MS proteomics. In addition we attempt to address the genomes contribution to the molecular systems that underlie MAB’s adaptation and persistence in the human host through an examination of MABs transcriptional response to a number of clinically relevant conditions. These include hypoxia, exposure to sub-inhibitory concentrations of antibiotics and growth in an artificial sputum designed to mimic the conditions within the cystic fibrosis lung.ConclusionsOur integrated map provides the first comprehensive view of the primary transcriptome of MAB and evidence for the translation of over one hundred new short open reading frames (sORFs). Our map will act as a resource for ongoing functional genomics characterization of MAB and our transcriptome data from clinically relevant stresses informs our understanding of MAB’s adaptation to life in the CF lung. MAB’s adaptation to growth in artificial CF sputum highlights shared metabolic strategies with other CF pathogens including P. aeruginosa and mirrors the transcriptional responses that lead to persistence in mycobacteria. These strategies include an increased reliance on amino acid metabolism, and fatty acid catabolism and highlights the relevance of the glyoxylate shunt to growth in the CF lung. Our data suggests that, similar to what is seen in chronically persisting P. aeruginosa, progression towards a biofilm mode of growth would play a more prominent role in a longer-term MAB infection. Finally, MAB’s transcriptional response to antibiotics highlights the role of antibiotic modifications enzymes, active transport and the evolutionarily conserved WhiB7 driven antibiotic resistance regulon.

[1]  J. Coppee,et al.  Identification and characterization of the genetic changes responsible for the characteristic smooth‐to‐rough morphotype alterations of clinically persistent Mycobacterium abscessus , 2013, Molecular microbiology.

[2]  G. Schoolnik,et al.  Cross-Reactive Immunity to Mycobacterium tuberculosis DosR Regulon-Encoded Antigens in Individuals Infected with Environmental, Nontuberculous Mycobacteria , 2009, Infection and Immunity.

[3]  Gary K. Schoolnik,et al.  The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species , 2011, Front. Microbio..

[4]  Peter M. Small,et al.  The W-Beijing Lineage of Mycobacterium tuberculosis Overproduces Triglycerides and Has the DosR Dormancy Regulon Constitutively Upregulated , 2007, Journal of bacteriology.

[5]  Y. Wolf,et al.  Small proteins can no longer be ignored. , 2014, Annual review of biochemistry.

[6]  M. Whiteley,et al.  Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum , 2015, Proceedings of the National Academy of Sciences.

[7]  S. Gordon,et al.  Relaxed Selection Drives a Noisy Noncoding Transcriptome in Members of the Mycobacterium tuberculosis Complex , 2014, mBio.

[8]  J. Betts,et al.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling , 2002, Molecular microbiology.

[9]  P. V. van Helden,et al.  A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[10]  S. Akhtar,et al.  Nitrite Reductase NirBD Is Induced and Plays an Important Role during In Vitro Dormancy of Mycobacterium tuberculosis , 2013, Journal of bacteriology.

[11]  Dirk Schnappinger,et al.  Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program , 2003, The Journal of experimental medicine.

[12]  A. Kolk,et al.  Potential biomarkers for identification of mycobacterial cultures by proton transfer reaction mass spectrometry analysis. , 2012, Rapid communications in mass spectrometry : RCM.

[13]  M. Son,et al.  In Vivo Evidence of Pseudomonas aeruginosa Nutrient Acquisition and Pathogenesis in the Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.

[14]  G. Besra,et al.  The Mycobacterium tuberculosis FAS‐II condensing enzymes: their role in mycolic acid biosynthesis, acid‐fastness, pathogenesis and in future drug development , 2007, Molecular microbiology.

[15]  Gene-Wei Li,et al.  The anti-Shine-Dalgarno sequence drives translational pausing and codon choice in bacteria , 2012, Nature.

[16]  Anna M. McGeachy,et al.  The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments , 2012, Nature Protocols.

[17]  Sreevalli Sharma,et al.  Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates , 2012, Antimicrobial Agents and Chemotherapy.

[18]  J. Arthur,et al.  Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. , 2010, Journal of medical microbiology.

[19]  C. Gee,et al.  A Phosphorylated Pseudokinase Complex Controls Cell Wall Synthesis in Mycobacteria , 2012, Science Signaling.

[20]  Lisa K. Woolhiser,et al.  Mycobacterium tuberculosis Lsr2 Is a Global Transcriptional Regulator Required for Adaptation to Changing Oxygen Levels and Virulence , 2014, mBio.

[21]  W. Meijer,et al.  The vapA co-expressed virulence plasmid gene vcgB (orf10) of the intracellular actinomycete Rhodococcus equi. , 2011, Microbiology.

[22]  M. Berney,et al.  Regulation of proline metabolism in mycobacteria and its role in carbon metabolism under hypoxia , 2012, Molecular microbiology.

[23]  H. Lai,et al.  Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus , 2015, Antimicrobial Agents and Chemotherapy.

[24]  Artem Cherkasov,et al.  The mycobacterial antibiotic resistance determinant WhiB7 acts as a transcriptional activator by binding the primary sigma factor SigA (RpoV) , 2013, Nucleic acids research.

[25]  Soumitra S Ghosh,et al.  Regulation of Lipid Biosynthesis, Sliding Motility, and Biofilm Formation by a Membrane-Anchored Nucleoid-Associated Protein of Mycobacterium tuberculosis , 2013, Journal of bacteriology.

[26]  R. Wallace,,et al.  A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2008, Antimicrobial Agents and Chemotherapy.

[27]  B. Gicquel,et al.  Mycobacterium abscessus: a new antibiotic nightmare. , 2012, The Journal of antimicrobial chemotherapy.

[28]  J. Heesemann,et al.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[29]  Axel Imhof,et al.  Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. , 2009, The Journal of infectious diseases.

[30]  Nicholas T Ingolia,et al.  Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. , 2014, Cell reports.

[31]  M. Chase,et al.  Leaderless Transcripts and Small Proteins Are Common Features of the Mycobacterial Translational Landscape , 2015, PLoS genetics.

[32]  G. Dougan,et al.  Sequence-Based Analysis Uncovers an Abundance of Non-Coding RNA in the Total Transcriptome of Mycobacterium tuberculosis , 2011, PLoS pathogens.

[33]  Zhidong Liu,et al.  Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level , 2016, Scientific Reports.

[34]  B. Ueberheide,et al.  Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence , 2016, Proceedings of the National Academy of Sciences.

[35]  A. Arkin,et al.  Comparative Genomics of the Dormancy Regulons in Mycobacteria ᰔ † , 2011 .

[36]  V. Barbe,et al.  Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus , 2009, PloS one.

[37]  J. Rolain,et al.  ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes , 2013, Antimicrobial Agents and Chemotherapy.

[38]  G. Bloemberg,et al.  Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria. , 2015, The Journal of antimicrobial chemotherapy.

[39]  David G. Russell,et al.  Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress* , 2013, The Journal of Biological Chemistry.

[40]  E. Groisman,et al.  A Bacterial mRNA Leader that Employs Different Mechanisms to Sense Disparate Intracellular Signals , 2010, Cell.

[41]  E. Groisman,et al.  Bacterial Mg2+ homeostasis, transport, and virulence. , 2013, Annual review of genetics.